STE vs. BSX
Compare and contrast key facts about STERIS plc (STE) and Boston Scientific Corporation (BSX).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: STE or BSX.
Correlation
The correlation between STE and BSX is 0.43, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
STE vs. BSX - Performance Comparison
Loading data...
Key characteristics
STE:
0.02
BSX:
1.88
STE:
0.38
BSX:
2.23
STE:
1.05
BSX:
1.36
STE:
0.18
BSX:
2.51
STE:
0.37
BSX:
10.24
STE:
9.02%
BSX:
3.80%
STE:
20.93%
BSX:
22.25%
STE:
-77.21%
BSX:
-89.15%
STE:
-5.99%
BSX:
-3.04%
Fundamentals
STE:
$22.90B
BSX:
$152.19B
STE:
$6.23
BSX:
$1.37
STE:
37.42
BSX:
75.09
STE:
5.17
BSX:
2.53
STE:
4.24
BSX:
8.67
STE:
3.47
BSX:
6.85
STE:
$3.98B
BSX:
$17.55B
STE:
$1.76B
BSX:
$11.79B
STE:
$1.02B
BSX:
$4.09B
Returns By Period
In the year-to-date period, STE achieves a 12.74% return, which is significantly lower than BSX's 15.26% return. Over the past 10 years, STE has underperformed BSX with an annualized return of 14.06%, while BSX has yielded a comparatively higher 19.21% annualized return.
STE
12.74%
4.55%
4.32%
0.38%
9.95%
14.06%
BSX
15.26%
9.91%
16.04%
41.40%
23.84%
19.21%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
STE vs. BSX — Risk-Adjusted Performance Rank
STE
BSX
STE vs. BSX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for STERIS plc (STE) and Boston Scientific Corporation (BSX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
STE vs. BSX - Dividend Comparison
STE's dividend yield for the trailing twelve months is around 0.96%, while BSX has not paid dividends to shareholders.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
STE STERIS plc | 0.96% | 1.06% | 0.90% | 0.97% | 0.68% | 0.81% | 0.93% | 1.22% | 1.35% | 1.57% | 1.27% | 1.36% |
BSX Boston Scientific Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
STE vs. BSX - Drawdown Comparison
The maximum STE drawdown since its inception was -77.21%, smaller than the maximum BSX drawdown of -89.15%. Use the drawdown chart below to compare losses from any high point for STE and BSX. For additional features, visit the drawdowns tool.
Loading data...
Volatility
STE vs. BSX - Volatility Comparison
The current volatility for STERIS plc (STE) is 5.19%, while Boston Scientific Corporation (BSX) has a volatility of 5.64%. This indicates that STE experiences smaller price fluctuations and is considered to be less risky than BSX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
STE vs. BSX - Financials Comparison
This section allows you to compare key financial metrics between STERIS plc and Boston Scientific Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
STE vs. BSX - Profitability Comparison
STE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, STERIS plc reported a gross profit of 610.33M and revenue of 1.37B. Therefore, the gross margin over that period was 44.5%.
BSX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Boston Scientific Corporation reported a gross profit of 3.21B and revenue of 4.66B. Therefore, the gross margin over that period was 68.8%.
STE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, STERIS plc reported an operating income of 245.29M and revenue of 1.37B, resulting in an operating margin of 17.9%.
BSX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Boston Scientific Corporation reported an operating income of 921.00M and revenue of 4.66B, resulting in an operating margin of 19.8%.
STE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, STERIS plc reported a net income of 173.53M and revenue of 1.37B, resulting in a net margin of 12.7%.
BSX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Boston Scientific Corporation reported a net income of 674.00M and revenue of 4.66B, resulting in a net margin of 14.5%.